These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 23199405

  • 1. Management of acute and refractory Kawasaki disease.
    Tacke CE, Burgner D, Kuipers IM, Kuijpers TW.
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1203-15. PubMed ID: 23199405
    [Abstract] [Full Text] [Related]

  • 2. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 3. Kawasaki disease: Medical therapies.
    Newburger JW.
    Congenit Heart Dis; 2017 Sep; 12(5):641-643. PubMed ID: 28580631
    [Abstract] [Full Text] [Related]

  • 4. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM, Shulman ST.
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [Abstract] [Full Text] [Related]

  • 5. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 7. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.
    Dhanrajani A, Yeung RSM.
    Curr Opin Rheumatol; 2017 Sep; 29(5):547-552. PubMed ID: 28661936
    [Abstract] [Full Text] [Related]

  • 8. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
    Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in the treatment of Kawasaki disease.
    Weng KP, Ou SF, Lin CC, Hsieh KS.
    J Chin Med Assoc; 2011 Nov 26; 74(11):481-4. PubMed ID: 22100015
    [Abstract] [Full Text] [Related]

  • 10. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, Pongpanich B.
    Asian Pac J Allergy Immunol; 2006 Mar 26; 24(1):27-32. PubMed ID: 16913186
    [Abstract] [Full Text] [Related]

  • 11. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
    Kossiva L, Karanassios E, Papadopoulos G, Karavanaki K.
    Cardiol Young; 2012 Aug 26; 22(4):461-5. PubMed ID: 21933460
    [Abstract] [Full Text] [Related]

  • 12. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Aug 26; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 13. Kawasaki disease: part II. Complications and treatment.
    Bayers S, Shulman ST, Paller AS.
    J Am Acad Dermatol; 2013 Oct 26; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [Abstract] [Full Text] [Related]

  • 14. Aspirin Dose in Kawasaki Disease: The Ongoing Battle.
    Dhanrajani A, Chan M, Pau S, Ellsworth J, Petty R, Guzman J.
    Arthritis Care Res (Hoboken); 2018 Oct 26; 70(10):1536-1540. PubMed ID: 29287309
    [Abstract] [Full Text] [Related]

  • 15. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Oct 26; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 16. [The role of immunosuppressive agents in Kawasaki disease: a discussion of two cases].
    Peyre M, Laroche C, Etchecopar C, Brosset P.
    Arch Pediatr; 2013 Jul 26; 20(7):748-53. PubMed ID: 23693156
    [Abstract] [Full Text] [Related]

  • 17. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
    Wang J, Chen H, Shi H, Zhang X, Shao Y, Hang B, Xu Z, Rong X, Chu M, Qiu H.
    Pediatr Rheumatol Online J; 2020 Jun 11; 18(1):48. PubMed ID: 32527316
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Pediatrics; 2004 Dec 11; 114(6):1708-33. PubMed ID: 15574639
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics.
    Circulation; 2004 Oct 26; 110(17):2747-71. PubMed ID: 15505111
    [Abstract] [Full Text] [Related]

  • 20. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
    Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Pürerfellner H, Liu S, Krucoff MW.
    JAMA Pediatr; 2016 Dec 01; 170(12):1156-1163. PubMed ID: 27749951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.